Liquidmetal® Technologies, Inc. (OTCQB: LQMT), the world's leading developer of amorphous alloys, announced today that prototype parts manufactured and delivered on an earlier order had successfully completed validation and acceptance testing. The strong performance of the initial prototypes led to a follow-on production order that Liquidmetal is now in the process of producing. The company also announced the receipt of a new order, our fourth to date, this one from a customer in the medical device field. "We have been focused on medical markets since training a new set of Manufacturing Sales Representatives (MSRs) and opening our Manufacturing Center of Excellence last fall. This new part represents an initial success within in this very important target market segment," said Paul Hauck, Vice President of World-Wide Sales and Support. About Liquidmetal Technologies Liquidmetal Technologies, Inc. is the leading developer of bulk alloys and composites that utilize the performance advantages offered by amorphous alloy technology. Amorphous alloys are unique materials that are distinguished by their ability to retain a random structure when they solidify, in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form, enabling significant improvements in products across a wide array of industries. For more information, go to www.liquidmetal.com.